Paper2331748
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
Zack JA and 5 others. Cell, 1990. Cited by 1,415 papers, by iCite.
Cite this record
ConductScience Library. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Papers, record 2331748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2331748
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV | Major topic |
| Lymphocyte Activation | Major topic |
| T-Lymphocytes | Major topic |
| Base Sequence | |
| DNA, Viral | |
| Gene Expression | |
| Genes, Viral | |
| HIV-1 | |
| Humans | |
| Molecular Sequence Data | |
| Oligonucleotide Probes | |
| Polymerase Chain Reaction | |
| RNA, Viral |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AI27221 | NIAID NIH HHS | United States | U01AI027221 | PubMed and NIH |
Source NIH RePORTER
Cited by698
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,415 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947143 | Virus-informed targeting of HIV reservoirs: Rev-dependent HIV Immunotherapy (RHIT). | Retrovirology | 2026 | https://conductscience.org/library/papers/42947143 | PubMed |
| 42092137 | HIV-1 signalling remodels nuclear pores to licence infection. | Nature | 2026 | https://conductscience.org/library/papers/42092137 | PubMed |
| 41942453 | In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity. | Nat Commun | 2026 | https://conductscience.org/library/papers/41942453 | PubMed |
| 41600872 | Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes. | Viruses | 2026 | https://conductscience.org/library/papers/41600872 | PubMed |
| 41000984 | Partially-functional exhausted CD8+ T cells can contribute to short-term viral suppression: a computational prediction for children with perinatal HIV. | bioRxiv | 2025 | https://conductscience.org/library/papers/41000984 | PubMed |
| 40934271 | Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40934271 | PubMed |
| 40464563 | Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure. | J Virol | 2025 | https://conductscience.org/library/papers/40464563 | PubMed |
| 40332080 | Prime Editing in Dividing and Quiescent Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332080 | PubMed |
| 40148322 | Keratin-72 restricts HIV-1 infection in resting CD4+ T cells by sequestering capsids in intermediate filaments. | Nat Commun | 2025 | https://conductscience.org/library/papers/40148322 | PubMed |
| 40048262 | Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40048262 | PubMed |
| 40044684 | Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse model. | Nat Commun | 2025 | https://conductscience.org/library/papers/40044684 | PubMed |
| 39066325 | HIV Persistence, Latency, and Cure Approaches: Where Are We Now? | Viruses | 2024 | https://conductscience.org/library/papers/39066325 | PubMed |
| 38765786 | Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells. | Pathog Immun | 2024 | https://conductscience.org/library/papers/38765786 | PubMed |
| 38675857 | Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies. | Viruses | 2024 | https://conductscience.org/library/papers/38675857 | PubMed |
| 38010468 | The Role of p53 in HIV Infection. | Curr HIV/AIDS Rep | 2023 | https://conductscience.org/library/papers/38010468 | PubMed |
| 37844236 | Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37844236 | PubMed |
| 37345240 | HIV Preintegration Transcription and Host Antagonism. | Curr HIV Res | 2023 | https://conductscience.org/library/papers/37345240 | PubMed |
| 37159665 | DNA ultra-sensitive quantification, a technology for studying HIV unintegrated linear DNA. | Cell Rep Methods | 2023 | https://conductscience.org/library/papers/37159665 | PubMed |
| 37111397 | HIV Infection Elicits Differential Transcriptomic Remodeling in CD4+ T Cells with Variable Proliferative Responses to the T Cell Receptor Stimulus. | Pathogens | 2023 | https://conductscience.org/library/papers/37111397 | PubMed |
| 37110276 | HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic". | Microorganisms | 2023 | https://conductscience.org/library/papers/37110276 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2331748
GET https://conductscience.org/api/papers/v1/2331748/cited_by?page=2